Clearmind Medicine Inc. announced the grant of a new U.S. Patent, No. 12,357,590, titled "BINGE BEHAVIOR REGULATORS," by the USPTO. This patent expand...
HRT Financial LP, a ten percent owner of Clearmind Medicine Inc. (CMND), sold 22,139 Class A Shares at $3.306 per share in an open-market transaction....
Clearmind Medicine Inc. has announced the successful completion of dosing for all 24 participants in Part A of its ongoing Phase I/II clinical trial f...
Neutral
This article details 12 healthcare stocks experiencing significant movement in Monday's pre-market session. It lists both gainers and losers, providin...